Posted by Michael Wonder on 28 Jul 2021
'New regulation limiting generic drugs will change industrial paradigm'
27 July 2021 - The Korea Pharmaceutical and Bio-pharma Manufacturers Association said the revision of the Pharmaceutical Affairs Act to restrict generic drugs would be an inflection point to bring about a paradigm shift in the biopharmaceutical industry.
The KPBMA made these and other points in its latest policy report in the form of a forum, "Biopharmaceutical industry in a transformational period."
